McKesson Corporation (MCK)
Summary
MCK Chart
Here's Why McKesson (MCK) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson Q1 Earnings Call Highlights
McKesson NYSE: MCK reported fiscal first-quarter 2027 results that exceeded its expectations, citing broad-based momentum across its operating businesses and prompting the healthcare services company to raise its full-year adjusted earnings outlook.
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
McKesson Corporation (MCK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has McKesson Corporation ever had a stock split?
McKesson Corporation Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Brian S. Tyler CEO | XETRA Exchange | US58155Q1031 ISIN |
| US Country | 42,300 Employees | 1 Sep 2026 Last Dividend | 5 Jan 1998 Last Split | 15 Nov 1994 IPO Date |
Overview
McKesson Corporation stands as a prominent provider of healthcare services not only within the United States but also on an international platform. With its foundation laid in 1833, the company has excelled in extending its footprint across various segments of the healthcare industry, making it headquartered in Irving, Texas. Operating through four main segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International, McKesson strives to address the variegated needs of the healthcare realm. These segments collaborate to distribute pharmaceuticals, offer technological and clinical solutions, and ensure necessary medical supplies reach healthcare providers efficiently.
Products and Services
- U.S. Pharmaceutical:
- Prescription Technology Solutions (RxTS):
- Medical-Surgical Solutions:
- International:
This segment is instrumental in distributing a vast array of pharmaceuticals, including branded, generic, specialty, biosimilar, and over-the-counter drugs. Furthermore, it caters to community-based oncology and other specialty practices by supplying practice management, technology, clinical support, and business solutions. Additionally, it encompasses services like consulting, outsourcing, technological offerings, and providing financial, operational, and clinical solutions targeted at pharmacies.
Under this banner, McKesson takes a significant step towards bridging the medication-related gaps between biopharma, life sciences partners, and patients by interlinking patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The RxTS segment aims at rolling out innovative solutions to streamline the process of medication acquisition, ensuring the delivery of medicine that enriches patient health. Services rendered include prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support.
This segment ensures the streamlined distribution of medical and surgical supplies, logistics, and other pivotal services to various healthcare settings, encompassing physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. It represents McKesson's commitment to providing essential supplies and services that support the health ecosystem's backbone, thereby enabling healthcare providers to deliver quality care.
McKesson's International segment focuses on the distribution of pharmaceuticals and medical supplies, along with rendering services to a vast customer base, including wholesale, institutional, and retail channels across Europe and Canada. This segment showcases the company's dedication to extending its healthcare services and products to a global audience, ensuring an international footprint in healthcare distribution and services.
